Neximmune Price on July 9, 2024
NEXIDelisted Stock | USD 2.43 0.22 9.95% |
If you're considering investing in Neximmune Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Neximmune stands at 2.43, as last reported on the 26th of November, with the highest price reaching 2.59 and the lowest price hitting 2.15 during the day. We have found twenty-four technical indicators for Neximmune, which you can use to evaluate the volatility of the firm. Please verify Neximmune's Standard Deviation of 10.32, risk adjusted performance of (0.01), and Mean Deviation of 4.85 to check out if the risk estimate we provide is consistent with the expected return of 0.0%.
Neximmune Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Neximmune |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
NEXI |
Based on monthly moving average Neximmune is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neximmune by adding Neximmune to a well-diversified portfolio.
Related Headline
ZyVersa Therapeutics Headline on 9th of July 2024
ZyVersa Therapeutics CEO, Stephen C. Glover, Is an Invited S... by finance.yahoo.com
ZyVersa is advancing a dynamic pipeline of drug candidates with multiple programs built around two proprietary technologies Phase 2a Cholesterol Efflux Mediator VAR 200 for treatment of kidney diseases, and Inflammasome ASC Inhibitor IC 100 for treatment of obesity and its associated metabolic complications, among other inflammatory diseases.Mr. Glover welcomes one-on-one meetings with registered participants. WESTON, Fla., July 09, 2024 -- ZyVersa Therapeutics, Inc. Nasdaq
Neximmune Valuation on July 9, 2024
It is possible to determine the worth of Neximmune on a given historical date. On July 9, 2024 Neximmune was worth 2.44 at the beginning of the trading date compared to the closed value of 2.28. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Neximmune pink sheet. Still, in general, we apply an absolute valuation method to find Neximmune's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Neximmune where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Neximmune's related companies.
Open | High | Low | Close | Volume | |
2.31 | 2.46 | 2.31 | 2.39 | 8,581 | |
07/09/2024 | 2.44 | 2.44 | 2.25 | 2.28 | 20,207 |
2.25 | 2.43 | 2.01 | 2.31 | 49,410 |
Backtest Neximmune | | | Neximmune History | | | Neximmune Valuation | Previous | Next |
Neximmune Trading Date Momentum on July 9, 2024
On July 10 2024 Neximmune was traded for 2.31 at the closing time. The top price for the day was 2.43 and the lowest listed price was 2.01 . The trading volume for the day was 49.4 K. The trading history from July 10, 2024 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 1.32% . The trading delta at closing time against the current closing price is 3.07% . |
Neximmune Fundamentals Correlations and Trends
By evaluating Neximmune's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Neximmune's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Neximmune financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Neximmune Pink Sheet history
Neximmune investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neximmune is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neximmune will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neximmune stock prices may prove useful in developing a viable investing in Neximmune
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland. Neximmune operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 74 people.
Neximmune Pink Sheet Technical Analysis
Neximmune technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Neximmune Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Neximmune cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Neximmune November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Neximmune pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neximmune shares will generate the highest return on investment. By undertsting and applying Neximmune pink sheet market strength indicators, traders can identify Neximmune entry and exit signals to maximize returns
Neximmune Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Neximmune's price direction in advance. Along with the technical and fundamental analysis of Neximmune Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neximmune to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.01) | |||
Jensen Alpha | (0.1) | |||
Total Risk Alpha | (1.94) | |||
Treynor Ratio | 0.1731 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Neximmune Pink Sheet
If you are still planning to invest in Neximmune check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neximmune's history and understand the potential risks before investing.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |